Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision tag (v3.4.2) and removal of a prior government funding notice; no changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA system notice about government funding lapse and NIH Clinical Center operations was added, and the site version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary toggle was added, and QC/version metadata updated to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The older QC wording and 'No FEAR Act data' phrasing were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The update affects page metadata and formatting but does not alter study details, participation criteria, or study results.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page shows a minor site update: Revision: v3.3.2 replacing v3.3.1; no study content or results are altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.